.jpeg@webp)
Press Release
PRIM&R Annual Conference in Denver Brings the Research Ethics and Oversight Community Together
FOR IMMEDIATE RELEASE
November 18, 2026 DENVER — Public Responsibility in Medicine and Research (PRIM&R) is concluding the 2026 PRIM&R Annual Conference today at the Colorado Convention Center in Denver, the final day of the three-day event. More than 2,000 people registered to join PRIM&R for the national conference to connect with, and learn from, those involved in research and research oversight.
PRIM&R’s annual conference is designed to educate and connect all those involved in research and research oversight, and to support the field in thinking holistically about the research enterprise. The PRIM&R community’s shared goal is advancing ethical, responsible, and high-quality research.
The conference began on Monday, November 16, with welcome remarks from PRIM&R Executive Director Ivy Tillman, EdD, CIP, and PRIM&R Board of Directors Chair Gianna McMillan, DBe, MFA.
During her remarks, Tillman discussed the public policy work PRIM&R has led over the last year. “Public policy is central to how we advocate for ethical research, and we’ve dramatically increased that work,” Tillman said. “We’ve weighed in on more issues, built and joined coalitions, and worked to build direct relationships with lawmakers and federal agency staff.”
“In January, as a new Congress is seated, we will continue to work to educate those new members and their policy staff about the important work that we all do together,” Tillman said.
The 2026 PRIM&R Annual Conference featured two keynote presentations this year. The first, “IRBs and the Research Trust Triad,” was delivered Tuesday morning by Matthew Wynia, MD, MPH, a professor of medicine at the University of Colorado. Wynia directs the university’s Center for Bioethics and Humanities and is a clinician-researcher and leader in bioethics with a history of exploring some of the most contentious ethical issues in health care.
The second keynote address, “Don’t Ask Patients to Be Superheroes,” was delivered today by Jane E. Myles, MSc, BScHon. Myles has worked in clinical drug development for nearly three decades and is vice president for programs and initiatives for the Digital Trials and Research Alliance (DTRA) in Canada.
Roughly 150 speakers participated in the 2026 PRIM&R Annual Conference. Sessions covered a wide range of topics, including animal care and use, human subjects research, and institutional leadership. The ethics track of the PRIM&R Annual Conference, “Navigating Ethical Challenges,” was developed through a local partnership with the University of Colorado Center for Bioethics and Humanities and the Research Ethics Program of the Colorado Clinical and Translational Sciences Institute (CCTSI).
Throughout the conference, representatives from federal agencies and accrediting bodies held office hours to answer attendee questions and engage in dialogue. Participating organizations included AAALAC International, the Association for the Accreditation of Human Research Protection Programs (AAHRPP), the National Center for Advancing Translational Sciences (NCATS), the Office for Human Research Protections (OHRP), and the Office of Research Integrity (ORI).
This year, attendees could choose conference days specific to their area of expertise, while still having the option to participate in the full conference. Animal Care and Use (ACU)/ Institutional Animal Care and Use Committee (IACUC) programming ran on Monday and Tuesday, and Human Subjects Research (HSR) and Institutional Leadership programming ran Tuesday and Wednesday.
“We want to ensure each community gets a more focused, tailored experience without losing the connections that make this conference so special,” Tillman said.
To see the full agenda of the conference, click here.
November 18, 2026 DENVER — Public Responsibility in Medicine and Research (PRIM&R) is concluding the 2026 PRIM&R Annual Conference today at the Colorado Convention Center in Denver, the final day of the three-day event. More than 2,000 people registered to join PRIM&R for the national conference to connect with, and learn from, those involved in research and research oversight.
PRIM&R’s annual conference is designed to educate and connect all those involved in research and research oversight, and to support the field in thinking holistically about the research enterprise. The PRIM&R community’s shared goal is advancing ethical, responsible, and high-quality research.
The conference began on Monday, November 16, with welcome remarks from PRIM&R Executive Director Ivy Tillman, EdD, CIP, and PRIM&R Board of Directors Chair Gianna McMillan, DBe, MFA.
During her remarks, Tillman discussed the public policy work PRIM&R has led over the last year. “Public policy is central to how we advocate for ethical research, and we’ve dramatically increased that work,” Tillman said. “We’ve weighed in on more issues, built and joined coalitions, and worked to build direct relationships with lawmakers and federal agency staff.”
“In January, as a new Congress is seated, we will continue to work to educate those new members and their policy staff about the important work that we all do together,” Tillman said.
The 2026 PRIM&R Annual Conference featured two keynote presentations this year. The first, “IRBs and the Research Trust Triad,” was delivered Tuesday morning by Matthew Wynia, MD, MPH, a professor of medicine at the University of Colorado. Wynia directs the university’s Center for Bioethics and Humanities and is a clinician-researcher and leader in bioethics with a history of exploring some of the most contentious ethical issues in health care.
The second keynote address, “Don’t Ask Patients to Be Superheroes,” was delivered today by Jane E. Myles, MSc, BScHon. Myles has worked in clinical drug development for nearly three decades and is vice president for programs and initiatives for the Digital Trials and Research Alliance (DTRA) in Canada.
Roughly 150 speakers participated in the 2026 PRIM&R Annual Conference. Sessions covered a wide range of topics, including animal care and use, human subjects research, and institutional leadership. The ethics track of the PRIM&R Annual Conference, “Navigating Ethical Challenges,” was developed through a local partnership with the University of Colorado Center for Bioethics and Humanities and the Research Ethics Program of the Colorado Clinical and Translational Sciences Institute (CCTSI).
Throughout the conference, representatives from federal agencies and accrediting bodies held office hours to answer attendee questions and engage in dialogue. Participating organizations included AAALAC International, the Association for the Accreditation of Human Research Protection Programs (AAHRPP), the National Center for Advancing Translational Sciences (NCATS), the Office for Human Research Protections (OHRP), and the Office of Research Integrity (ORI).
This year, attendees could choose conference days specific to their area of expertise, while still having the option to participate in the full conference. Animal Care and Use (ACU)/ Institutional Animal Care and Use Committee (IACUC) programming ran on Monday and Tuesday, and Human Subjects Research (HSR) and Institutional Leadership programming ran Tuesday and Wednesday.
“We want to ensure each community gets a more focused, tailored experience without losing the connections that make this conference so special,” Tillman said.
To see the full agenda of the conference, click here.
About PRIM&R
Since 1974, PRIM&R has advanced the highest ethical standards in the conduct of research. We accomplish this mission through education, membership services, professional certification, public policy initiatives, and community building. PRIM&R is a 501(c)3 nonprofit. Find out more at www.primr.org
Media Contact:
Daniel McLean
Public Engagement Manager
Public Responsibility in Medicine and Research (PRIM&R)
Direct: 617-303-1877
dmclean@primr.org
www.primr.org